You are viewing one of our archived events - do you want to be redirected to the latest conference in this series? Go to last event
February 9th 2012
- Hotel Russell, London
THE STRATEGIC EVENT FOR THE PHARMA INDUSTRY
Over 200 senior executives from the pharma industry attended this year's summit. 84% of the audience was director level or above and eight of the world’s top ten pharmaceutical companies were present.
The pharma industry is facing some difficult strategic choices. As the costs of R&D escalate, other more reliable revenue streams look increasingly attractive.
What are the best bets? Will big pharma in its current incarnation even be around in ten years time? And will it be new business models or technological innovations that fundamentally change the industry?
Now in its 18th year, our annual summit identifies those trends that have the potential to truly transform the pharmaceutical industry. Chaired by Geoffrey Carr, Science Editor, The Economist this summit will bring together leading thinkers and experts, who will unlock a fresh perspective. Attend this event to:
GAIN INSIGHT from leading global experts
DISCOVER new perspectives on the key strategic issues facing Pharma
LEARN about new innovations, trends and ideas that will shape the industry
BE INSPIRED by a forward-thinking agenda that challenges
- Emerging healthcare models and the role pharma can play in this
- The real implications of patient-centric healthcare
- The game changers: the innovations that will transform the industry
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
| 08.15 | REGISTRATION AND NETWORKING BREAKFAST |
| 09.00 | CHAIR'S OPENING REMARKS Geoffrey Carr, Science Editor, The Economist |
| 09.10 | OPENING ADDRESS: Adding value - a CFO's perspective on driving shareholder returns in a more challenging world Simon Dingemans, Chief Financial Officer, GlaxoSmithKline |
| 09.40 | PANEL DISCUSSION: Pharma and the global healthcare picture Nina Schwalbe, Managing Director, Policy and Performance, Global Alliance for Vaccines and Immunization (GAVI) Bruno Strigini, President, Europe/Canada, Merck Stephen Whitehead, Chief Executive Officer, Association for the British Pharmaceutical Industry (ABPI) |
| 10.40 | NETWORKING BREAK |
| 11.10 | DISCUSSION: Putting the patient at the centre Patrick Flochel, Partner, EMEIA Life Sciences Leader, Ernst & Young Theresa Heggie, Senior Vice-president, Global Commercial Operations, Shire HGT John Pottage, Chief Scientific and Medical Officer, ViiV Healthcare Wendy White, Founder and President, Siren Interactive |
| 12.20 | A CONVERSATION WITH... Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence (NICE) Interviewed by Iain Scott, Managing Editor, Thought Leadership, Economist Intelligence Unit |
| 12.40 | LUNCH |
| 13.50 | BIG PHARMA OR BIG IDEAS: WHO WILL CHANGE THE GAME? DEBATE: Is scientific innovation in the pharma industry rewarded? Andrew Baum, Managing Director, European Pharmaceuticals, Citi Anders Ekblom, Associate Professor; Executive Vice-president and Head of R&D Science and Technology Integration, AstraZeneca |
| 14.25 | KEYNOTE ADDRESS: Has biotech’s time finally come? Simon Moroney, Chief Executive Officer, MorphoSys |
| 14.55 | HOW PATIENT DATA WILL TRANSFORM THE PHARMA INDUSTRY Brian Griffin, Chief Executive Officer, Medco International |
| 15.25 | NETWORKING BREAK |
| 15.45 | THE FUTURE OF MEDICINE – the disruptive innovators Freda Lewis-Hall, Chief Medical Officer and Executive Vice-president, Pfizer |
| 16.15 | CLOSING KEYNOTE: Innovation and global health – is anyone changing the game? Tachi Yamada, Chief Medical and Scientific Officer, Executive Vice-president and Board Member, Takeda Pharmaceuticals |
| 16.45 | CHAIR'S CLOSING REMARKS Geoffrey Carr, Science Editor, The Economist |
| 16.50 | CLOSE OF SUMMIT AND DRINKS RECEPTION |
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
We would be delighted if you could join us after the summit for a drinks reception.
Join Olympic, Paralympic and World Champions, who are representing the Dame Kelly Holmes Legacy Trust. This charity supports disadvantaged young people through mentoring from world class athletes, getting them fit for work and fit for life.
This is free to attend for all attendees of the summit so why not continue the discussions of the day with your peers over a drink. We look forward to seeing you there.
17.00 Opening: Olympic, Paralympic and World Champions
Charles Cousins International – Rowing
Adam Whitehead Olympian - Swimming
Pippa Wilson Olympian – Sailing
17.05 Drinks Reception
18.30 Close
 | Adam Whitehead Olympian - Swimming |  | Pippa Wilson Olympian – Sailing |  | Charles Cousins International – Rowing |
Sponsored by:
|
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
CONFERENCE CHAIR: Geoffrey Carr, Science Editor, The Economist
With specialist areas of interest ranging from Aids research through genomics and synthetic biology, Geoff will ensure the Pharma Summit delves deep into the critical issues and will bring the best out of speakers and panellists.
Tachi Yamada, Chief Medical and Scientific Officer, Executive Vice-president and Board Member, Takeda Pharmaceuticals International
A veteran of the pharma industry and former president of the Global Health Program at the Bill and Melinda Gates Foundation, Dr Yamada will give his predictions for the companies and innovations that will revolutionise healthcare across the globe.
Simon Dingemans, Chief Financial Officer, GlaxoSmithKline
As CFO of one of the world’s largest pharma companies, and with a 25-year background in investment banking, Simon is the ideal person to give us the investor community perspective on Big Pharma and how the industry can really add value.
Sir Andrew Dillon, Chief Executive, National Institute of Health and Clinical Excellence (NICE)
NICE is now world renown as a provider of advice on medical care, quality and standards, and Sir Andrew, who has been there since it was founded.
Anders Ekblom, Associate Professor; Executive Vice President and Head of R&D Science and Technology Integration, AstraZeneca
Dr Ekblom is a veteran of the pharma industry and as head of global drug development for one of its biggest players.
Brian Griffin, Chief Executive Officer, Medco International
As head of Medco International Brian focuses on improving the quality of care for patients and therapeutic outcomes. He will talk about the potential in patient data to create value in pharma and healthcare.
Wendy White, Founder and President, Siren Interactive
Founder of Siren Interactive, a relationship marketing company for rare disorder therapies, Wendy is considered a thought leader in building trust relationships and communities online.
Nina Schwalbe, Managing Director, Policy and Performance, Global Alliance for Vaccines and Immunization
As policy director for GAVI, an organisation whose mission is to fund vaccines for children in the world’s 70 poorest countries, Nina will talk about some of the major challenges in this area,
Bruno Strigini, President, Europe/Canada, Merck
With an extensive background in the international pharmaceutical industry, Bruno will bring a wealth of experience to the session on the future of global healthcare and the opportunities for pharma.
Freda Lewis-Hall, Chief Medical Officer and Executive Vice-president, Pfizer
Dr Hall has had a long and distinguished career in roles spanning medical research, academia and patient advocacy among others. And she will share with us her thoughts and ideas on the future of innovation in medicine.
Patrick Flochel, Partner, EMEIA Life Sciences Leader, Ernst & Young
Patrick’s work with major global clients in the EMEIA region in the life sciences, pharma and medical devices sectors ensures that he will have a truly informed perspective.
Stephen Whitehead, Chief Executive Officer, Association of the British Pharmaceutical Industry
Stephen Whitehead is the chief advocate for the research-based pharmaceutical industry in the UK and joins at a key period of change and modernisation.
Simon Moroney, Chief Executive Officer, MorphoSys
The scientist and entrepreneur Dr Simon Moroney will explain why he sees a future in biotech, and the role that the industry will play in tomorrow’s healthcare landscape.
Theresa Heggie, Senior Vice-president, Global Commercial Operations, Shire HGT
Theresa has over 20 years of experience in the pharma and biotech industries, and will focus on how patient needs are being met in the area of rare and orphan diseases.
Andrew Baum, Managing Director, European Pharmaceuticals, Citi
Dr Baum is not only a trained physician but has also been name no.1 pharmaceuticals analyst in the Thomson Reuters Excel rankings four years running.
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
Gold Sponsor:
|
Sliver Sponsor:
Quintiles is the only fully integrated biopharmaceutical services provider offering clinical, commercial, consulting and capital solutions worldwide. Our more than 24,000 employees in nearly 60 countries help customers manage change, navigate risk and seize opportunities in the new health landscape. Quintiles has helped develop or commercialize all of the top 30 best-selling drugs |
Exhibitors:
Catenion is a management consulting firm devoted to helping pharmaceutical and medical products companies create more innovative and effective strategies and organisations and significantly increase their returns on R&D. We greatly improve how our clients assess the value and risk of their project and product portfolios and how they allocate resources. |
The Global leader in Market Access and Named Patient Supply with a 30 year heritage of working with Manufacturers, Hospitals, Governments and individual patients. Strategically located on 4 continents makes us the truly global solution to your supply needs. "Improving lives through patient access" is our mission. |
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
Media Partners:
PharmaTimes Magazine was launched in 1988. The PharmaTimes portfolio includes the well-respected monthly industry Magazine; three news elert services including World, UK and Clinical news; business forums, where thought-leaders meet to discuss the issues of the day; and a unique series of awards that recognise, reward and celebrate excellence. |
SCRIPIntelligence is the leading source of pharmaceutical and biotech news, analysis and data, providing expert knowledge on global pharma issues from M&A deals and business to R&D, drug delivery and clinical trials. SCRIP analyses significant facts, trends and predictions to save you time and give you invaluable insight. Visit www.scripintelligence.com for free trial access.
|
www.pharmaphorum.com is the dynamic online information and discussion portal for the pharmaceutical industry. Designed to keep you one step ahead in today’s busy world of fast media it brings together. Pay us a visit today to stay informed on the latest trends in the world of pharma and also receive special offers and promotions. More features coming soon!
|
PharmaVentures Limited is a leading international corporate advisory firm supporting its clients' growth ambitions in the health care industry. It produces the highly popular PharmaDeals® www.pharmadeals.net range of intelligence products including analysis tools and reports, as well as the world's first dedicated online pharmaceutical television channel, PharmaTelevision® www.pharmatelevision.com |
Thomson Reuters can provide the knowledge, tools and expertise to help support your drug discovery and development activities, optimize your IP portfolio, identify licensing and partnering opportunities, deliver successful regulatory submissions, keep you in touch with the rapidly-changing pharmaceutical and chemical markets, and make informed, early decisions. |
 |
Supporting PR Agency:
M:Communications is Europe’s fastest growing and most sought after cross-border communications agency. M:’s highly experienced international healthcare team is renowned as a market leader internationally with a deep knowledge, passion and understanding of the sector and a proven track record in offering a fully integrated service to global healthcare clients. |
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
To view the available speaker presentations from the day please click on their picture below.
*Please note that the presentations are password protected.
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
Inventing and making drugs has always been the lifeblood of the pharma industry. But the current way of doing this is no longer feasible. Should pharma cut its losses and get out of R&D, or does it still have a role to play in medical research? Join us and our experts to debate the REAL BUSINESS of pharma.
Now in its 18th year, our annual Pharma Summit will this year look at the emerging healthcare models and discuss what part pharma will play over the next five to ten years.
How can pharma rebuild its image and position itself as a key industry in tomorrow’s marketplace? Join the debate where top pharma players will share their thoughts on the out look for the pharma industry in the long term and discuss the business models for future success.
Technology, reform and innovation are driving significant changes in how healthcare is delivered. The pharma industry will play a crucial role in shaping this, but will need to innovate to stay ahead. Join us at The Pharma Summit to understand how firms can take advantage of these developments.
DOWNLOAD THE BROCHURE
The Pharma Summit Brochure 2012Gold sponsor:
Send to friend
